Bladder cancer and urothelial impairment: The role of TRPV1 as potential drug target

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Mistretta, Francesco ^a   Buffi, Nicolò Maria ^a   Lughezzani, Giovanni ^a   Lista, Giuliana ^a   Larcher, Alessandro ^a   Fossati, Nicola ^a   Abrate, Alberto ^a   Dell'Oglio, Paolo ^a   Montorsi, Francesco ^a   Guazzoni, Giorgio ^a   Lazzeri, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; VANILLOID RECEPTOR 1; ANTINEOPLASTIC AGENT; VANILLOID RECEPTOR;

ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BLADDER CARCINOGENESIS; DRUG TARGETING; HUMAN; INFLAMMATION; KIDNEY CANCER; PROSTATE CANCER; REVIEW; UROGENITAL TRACT TUMOR; UROTHELIUM; ANIMAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; METABOLISM; PROCEDURES; URINARY BLADDER NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; TRPV CATION CHANNELS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84901772337     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/987149     Document Type: Review

References (102)

1. Lecci A., Giuliani S., Lazzeri M., Benaim G., Turini D., Maggi C. A., The behavioral response induced by intravesical instillation of capsaicin in rats is mediated by pudendal urethral sensory fibers. Life Sciences 1994 55 6 429 436 2-s2.0-0028242844 10.1016/0024-3205(94)90054-X (Pubitemid 24227620)
2. Lazzeri M., Barbanti G., Beneforti P., Maggi C. A., Taddei I., Andrea U., Cantini C., Castellani S., Turini D., Vesical-renal reflex: diuresis and natriuresis activated by intravesical capsaicin. Scandinavian Journal of Urology and Nephrology 1995 29 1 39 43 2-s2.0-0028926529
3. Lazzeri M., Beneforti P., Benaim G., Maggi C. A., Lecci A., Turini D., Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study. Journal of Urology 1996 156 3 947 952 2-s2.0-0029776444 (Pubitemid 26269807)
4. Giuliani S., Patacchini R., Lazzeri M., Benaim G., Turini D., Quartara L., Maggi C. A., Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated urinary bladder. Journal of Autonomic Pharmacology 1996 16 5 251 259 2-s2.0-0030458321 (Pubitemid 27026508)
5. Lazzeri M., Beneforti P., Turini D., Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. Journal of Urology 1997 158 6 2093 2096 2-s2.0-0030780980 10.1016/S0022-5347(01) 68164-3 (Pubitemid 27481334)
6. Lazzeri M., Beneforti P., Spinelli M., Zanollo A., Barbagli G., Turini D., Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. Journal of Urology 2000 164 3, part 1 676 679 2-s2.0-0033897376 (Pubitemid 30637600)
7. Lazzeri M., Spinelli M., Zanollo A., Turini D., Intravesical vanilloids and neurogenic incontinence: ten years experience. Urologia Internationalis 2004 72 2 145 149 2-s2.0-1242306589 10.1159/000075969 (Pubitemid 38223800)
8. Lecci A., Maggi C. A., Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regulatory Peptides 2001 101 1-3 1 18 2-s2.0-0035885406 10.1016/S0167-0115(01)00285-3 (Pubitemid 32728365)
9. Maggi C. A., The dual function of capsaicin-sensitive sensory nerves in the bladder and urethra. Ciba Foundation symposium 1990 151 77 83 2-s2.0-0025116965
10. Caterina M. J., Schumacher M. A., Tominaga M., Rosen T. A., Levine J. D., Julius D., The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997 389 6653 816 824 2-s2.0-0030777012 10.1038/39807 (Pubitemid 27462969)
11. Hiura A., Nakae Y., Nakagawa H., Cell death of primary afferent nerve cells in neonatal mice treated with capsaicin. Anatomical Science International 2002 77 1 47 50 2-s2.0-0036517299
12. Lee Y. S., Nam D. H., Kim J.-A., Induction of apoptosis by capsaicin in A172 human glioblastoma cells. Cancer Letters 2000 161 1 121 130 2-s2.0-0034624342 10.1016/S0304-3835(00)00608-X
13. Macho A., Calzado M. A., Muñoz-Blanco J., Gómez-Díaz C., Gajate C., Mollinedo F., Navas P., Muñoz E., Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death and Differentiation 1999 6 2 155 165 2-s2.0-0032997385 (Pubitemid 29082304)
14. Jung M.-Y., Kang H.-J., Moon A., Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Letters 2001 165 2 139 145 2-s2.0-0035953849 10.1016/S0304-3835(01)00426- 8 (Pubitemid 32244170)
15. Jambrina E., Alonso R., Alcalde M., Rodríguez M. D. C., Serrano A., Martínez-A. C., García-Sancho J., Izquierdo M., Calcium influx through receptor-operated channel induces mitochondria-triggered paraptotic cell death. Journal of Biological Chemistry 2003 278 16 14134 14145 2-s2.0-0038529694 10.1074/jbc.M211388200 (Pubitemid 36799960)
16. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2013. CA Cancer Journal for Clinicians 2013 63 1 11 30
17. Brausi M., Witjes J. A., Lamm D., Persad R., Palou J., Colombel M., Buckley R., Soloway M., Akaza H., Böhle A., A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the international bladder cancer group. Journal of Urology 2011 186 6 2158 2167 2-s2.0-80755172266 10.1016/j.juro.2011.07.076
18. de Nunzio C., Carbone A., Albisinni S., Alpi G., Cantiani A., Liberti M., Tubaro A., Iori F., Long-term experience with early single Mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial. World Journal of Urology 2011 29 4 517 521 2-s2.0-79960697525 10.1007/s00345-011-0691-2
19. Perlis N., Zlotta A. R., Beyene J., Finelli A., Fleshner N. E., Kulkarni G. S., Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. European Urology 2013 64 3 421 430 10.1016/j.eururo.2013.06.009
20. Hou J. C.-T., Landas S., Wang C. Y., Shapiro O., Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model. Anticancer Research 2011 31 3 929 932 2-s2.0-79956066214
21. Aagaard M. F., Mogensen K., Hermann G. G., Delayed healing at transurethral resection of bladder tumour sites after immediate postoperative mitomycin C instillation. Scandinavian Journal of Urology 2013 48 2 222 224
22. Tolley D. A., Parmar M. K. B., Grigor K. M., Lallemand G., Beynon L. L., Fellows S. J., Freedman L. S., Hall R. R., Hargreave T. B., Munson K., Newling D. W. W., Richards B., Robinson M. R. G., Rose M. B., Smith P. H., Williams J. L., Whelan P., The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of followup. Journal of Urology 1996 155 4 1233 1238 2-s2.0-9044253710 10.1016/S0022- 5347(01)66226-8 (Pubitemid 26081202)
23. Sylvester R. J., Oosterlinck W., van Der Meijden A. P. M., A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. Journal of Urology 2004 171 6, part 1 2186 2190 2-s2.0-2442581163 10.1097/01.ju.0000125486.92260.b2 (Pubitemid 38625431)
24. Barocas D. A., Liu A., Burks F. N., Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer. The Journal of Urology 2013 190 6 2011 2016 10.1016/j.juro.2013.06.025
25. Birder L. A., Ruggieri M., Takeda M., Van Koeveringe G., Veltkamp S., Korstanje C., Parsons B., Fry C. H., How does the urothelium affect bladder function in health and disease?: ICI-RS 2011. Neurourology and Urodynamics 2012 31 3 293 299 2-s2.0-84859100133 10.1002/nau.22195
26. Costantini E., Lazzeri M., Pistolesi D., Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic Acid-chondroitin sulphate (ialuril(R)). Urologia Internationalis 2013 91 1 81 88 10.1159/000345047
27. Bassi P. F., Volpe A., D'Agostino D., Palermo G., Renier D., Franchini S., Rosato A., Racioppi M., Paclitaxel-hyaluronic acid for intravesical therapy of bacillus calmette-gurin refractory carcinoma in situ of the bladder: results of a phase i study. Journal of Urology 2011 185 2 445 449 2-s2.0-78651289804 10.1016/j.juro.2010.09.073
28. Apodaca G., The uroepithelium: not just a passive barrier. Traffic 2004 5 3 117 128 2-s2.0-1642305007 10.1046/j.1600-0854.2003.00156.x (Pubitemid 38379932)
29. Birder L. A., Wolf-Johnston A. S., Chib M. K., Buffington C. A., Roppolo J. R., Hanna-Mitchell A. T., Beyond neurons: involvement of urothelial and glial cells in bladder function. Neurourology and Urodynamics 2010 29 1 88 96 2-s2.0-76049085259 10.1002/nau.20747
30. Janssen D. A., van Wijk X. M., Jansen K. C., van Kuppevelt T. H., Heesakkers J. P., Schalken J. A., The distribution and function of chondroitin sulfate and other sulfated glycosaminoglycans in the human bladder and their contribution to the protective bladder barrier. The Journal of Urology 2013 189 1 336 342 10.1016/j.juro.2012.09.022
31. Hurst R. E., Roy J. B., Min K. W., Veltri R. W., Marley G., Patton K., Shackelford D. L., Stein P., Parsons C. L., A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology 1996 48 5 817 821 2-s2.0-0030298183 10.1016/S0090-4295(96)00322-6 (Pubitemid 26398711)
32. Ananthasubramaniam K., Weiss R., McNutt B., Klauke B., Feaheny K., Bukofzer S., A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease. Journal of Nuclear Cardiology 2012 19 2 319 329 2-s2.0-84855777969 10.1007/s12350-011-9508-3
33. Geppetti P., Nassini R., Materazzi S., Benemei S., The concept of neurogenic inflammation. BJU International, Supplement 2008 101 3 2 6 2-s2.0-40149100186 10.1111/j.1464-410X.2008.07493.x (Pubitemid 351328798)
34. Damiano R., Quarto G., Bava I., Ucciero G., De Domenico R., Palumbo M. I., Autorino R., Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. European Urology 2011 59 4 645 651 2-s2.0-79952282621 10.1016/j.eururo.2010.12.039
35. Birder L. A., Ruan H. Z., Chopra B., Xiang Z., Barrick S., Buffington C. A., Roppolo J. R., Ford A. P. D. W., De Groat W. C., Burnstock G., Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. The American Journal of Physiology-Renal Physiology 2004 287 5 F1084 F1091 2-s2.0-6344223431 10.1152/ajprenal.00118.2004 (Pubitemid 39391107)
36. Birder L. A., Apodaca G., De Groat W. C., Kanai A. J., Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. The American Journal of Physiology-Renal Physiology 1998 275 2, part 2 F226 F229 2-s2.0-0031846997
37. Chopra B., Barrick S. R., Meyers S., Beckel J. M., Zeidel M. L., Ford A. P. D. W., de Groat W. C., Birder L. A., Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. Journal of Physiology 2005 562 3 859 871 2-s2.0-13844280353 10.1113/jphysiol.2004. 071159 (Pubitemid 40246799)
38. Giglio D., Tobin G., Muscarinic receptor subtypes in the lower urinary tract. Pharmacology 2009 83 5 259 269 2-s2.0-62349137948 10.1159/000209255
39. Birder L. A., Urothelial signaling. Autonomic Neuroscience: Basic and Clinical 2010 153 1-2 33 40 2-s2.0-73949125284 10.1016/j.autneu.2009.07.005
40. Lazzeri M., Costantini E., Porena M., TRP family proteins in the lower urinary tract: translating basic science into new clinical prospective. Therapeutic Advances in Urology 2009 1 1 33 42 10.1177/1756287209103922
41. Stein R. J., Santos S., Nagatomi J., Hayashi Y., Minnery B. S., Xavier M., Patel A. S., Nelson J. B., Futrell W. J., Yoshimura N., Chancellor M. B., De Miguel F., Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. Journal of Urology 2004 172 3 1175 1178 2-s2.0-4143090474 10.1097/01.ju.0000134880.55119.cf (Pubitemid 39096495)
42. Streng T., Axelsson H. E., Hedlund P., Andersson D. A., Jordt S. E., Bevan S., Andersson K. E., Högestätt E. D., Zygmunt P. M., Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. European Urology 2008 53 2 391 399 10.1016/j.eururo.2007. 10.024 (Pubitemid 350296588)
43. Andersson K.-E., Gratzke C., Hedlund P., The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU International 2010 106 8 1114 1127 2-s2.0-77957602087 10.1111/j.1464-410X.2010.09650.x
44. Maggi C. A., Santicioli P., Geppetti P., The contribution of capsaicin-sensitive innervation to activation of the spinal vesico-vesical reflex in rats: relationship between substance P levels in the urinary bladder and the sensory-efferent function of capsaicin-sensitive sensory neurons. Brain Research 1987 415 1 1 13 2-s2.0-0023261881 (Pubitemid 17097370)
45. Sculptoreanu A., De Groat W. C., Tony Buffington C. A., Birder L. A., Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Experimental Neurology 2005 193 2 437 443 2-s2.0-18144416942 10.1016/j.expneurol.2005.01.011 (Pubitemid 40616192)
46. Dinis P., Charrua A., Avelino A., Yaqoob M., Bevan S., Nagy I., Cruz F., Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. Journal of Neuroscience 2004 24 50 11253 11263 2-s2.0-10644240899 10.1523/JNEUROSCI.2657-04.2004 (Pubitemid 39658260)
47. Lazzeri M., Montorsi F., The therapeutic challenge of "chronic cystitis": search well, work together, and gain results. European Urology 2011 60 1 78 80 2-s2.0-79957932572 10.1016/j.eururo.2011.03.039
48. Carter B. D., Kaltschmidt C., Kaltschmidt B., Offenhäuser N., Böhm-Matthaei R., Baeuerle P. A., Barde Y.-A., Selective activation of NF- B by nerve growth factor through the neurotrophin receptor p75. Science 1996 272 5261 542 545 2-s2.0-0029869593 (Pubitemid 26138196)
49. Iavazzo C., Athanasiou S., Pitsouni E., Falagas M. E., Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? European Urology 2007 51 6 1534 1541 2-s2.0-34247332338 10.1016/j.eururo.2007.03.020 (Pubitemid 46634772)
50. Montell C., Rubin G. M., Molecular characterization of the drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 1989 2 4 1313 1323 2-s2.0-0024642547
51. Skryma R., Prevarskaya N., Gkika D., Shuba Y., From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nature Reviews Urology 2011 8 11 617 630 2-s2.0-81055144300 10.1038/nrurol.2011.142
52. Yu W., Hill W. G., Apodaca G., Zeidel M. L., Expression and distribution of transient receptor potential (TRP) channels in bladder epithelium. The American Journal of Physiology-Renal Physiology 2011 300 1 F49 F59 2-s2.0-78651304019 10.1152/ajprenal.00349.2010
53. Everaerts W., Gevaert T., Nilius B., De Ridder D., On the origin of bladder sensing: Tr(i)ps in urology. Neurourology and Urodynamics 2008 27 4 264 273 10.1002/nau.20511 (Pubitemid 351656394)
54. Birder L., Andersson K. E., Urothelial signaling. Physiological Reviews 2013 93 2 653 680
55. Szallasi A., Conte B., Goso C., Blumberg P. M., Manzini S., Characterization of a peripheral vanilloid (capsaicin) receptor in the urinary bladder of the rat. Life Sciences 1993 52 20 L-221 L-226 2-s2.0-0027411411
56. Lazzeri M., Vannucchi M. G., Zardo C., Spinelli M., Beneforti P., Turini D., Faussone-Pellegrini M.-S., Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder. European Urology 2004 46 6 792 798 2-s2.0-8444225457 10.1016/j.eururo.2004.08.007 (Pubitemid 39488415)
57. Birder L. A., Nakamura Y., Kiss S., Nealen M. L., Barrick S., Kanai A. J., Wang E., Ruiz G., De Groat W. C., Apodaca G., Watkins S., Caterina M. J., Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nature Neuroscience 2002 5 9 856 860 2-s2.0-0036728668 10.1038/nn902 (Pubitemid 34976650)
58. Avelino A., Cruz F., TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. Naunyn-Schmiedeberg's Archives of Pharmacology 2006 373 4 287 299 2-s2.0-33745726257 10.1007/s00210-006-0073-2 (Pubitemid 43999780)
59. Daly D., Rong W., Chess-Williams R., Chapple C., Grundy D., Bladder afferent sensitivity in wild-type and TRPV1 knockout mice. Journal of Physiology 2007 583 2 663 674 2-s2.0-34548312495 10.1113/jphysiol.2007.139147 (Pubitemid 47343496)
60. Maggi C. A., Barbanti G., Santicioli P., Beneforti P., Misuri D., Meli A., Turini D., Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. Journal of Urology 1989 142 1 150 154 2-s2.0-0024324862 (Pubitemid 19184028)
61. Cruz F., Guimarães M., Silva C., Rio M. E., Coimbra A., Reis M., Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. Journal of Urology 1997 157 2 585 589 2-s2.0-18544405115 10.1016/S0022-5347(01)65211-X (Pubitemid 27026844)
62. Payne C. K., Mosbaugh P. G., Forrest J. B., Evans R. J., Whitmore K. E., Antoci J. P., Perez-Marrero R., Jacoby K., Diokno A. C., O'Reilly K. J., Griebling T. L., Vasavada S. P., Yu A. S., Frumkin L. R., Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. Journal of Urology 2005 173 5 1590 1594 2-s2.0-20244375697 10.1097/01.ju.0000154631.92150.ef (Pubitemid 40524779)
63. Kunzelmann K., Ion channels and cancer. Journal of Membrane Biology 2005 205 3 159 173 2-s2.0-29144506662 10.1007/s00232-005-0781-4 (Pubitemid 41803693)
64. Tsavaler L., Shapero M. H., Morkowski S., Laus R., Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Research 2001 61 9 3760 3769 2-s2.0-0035328671 (Pubitemid 32694990)
65. Fuessel S., Sickert D., Meye A., Klenk U., Schmidt U., Schmitz M., Rost A.-K., Weigle B., Kiessling A., Wirth M. P., Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR. International Journal of Oncology 2003 23 1 221 228 2-s2.0-1542435535
66. 2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 2003 22 49 7858 7861 2-s2.0-0345304866 10.1038/sj.onc.1206895 (Pubitemid 37485545)
67. Kalogris C., Caprodossi S., Amantini C., Lambertucci F., Nabissi M., Morelli M. B., Farfariello V., Filosa A., Emiliozzi M. C., Mammana G., Santoni G., Expression of transient receptor potential vanilloid-1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters. Histopathology 2010 57 5 744 752 2-s2.0-78449304113 10.1111/j.1365-2559.2010.03683.x
68. Lopez-Carrillo L., Avila M. H., Dubrow R., Chili pepper consumption and gastric cancer in Mexico: a case-control study. The American Journal of Epidemiology 1994 139 3 263 271 2-s2.0-0028008659 (Pubitemid 24062763)
69. 2+-mediated mitochondrial damage and cytochrome c release. Journal of Immunology 2006 177 7 4322 4329 2-s2.0-33749130615 (Pubitemid 44469760)
70. Amantini C., Mosca M., Nabissi M., Lucciarini R., Caprodossi S., Arcella A., Giangaspero F., Santoni G., Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. Journal of Neurochemistry 2007 102 3 977 990 2-s2.0-34447316691 10.1111/j.1471-4159. 2007.04582.x (Pubitemid 47057292)
71. Shin D.-H., Kim O.-H., Jun H.-S., Kang M.-K., Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway. Experimental and Molecular Medicine 2008 40 5 486 494 2-s2.0-57349126316 10.3858/emm.2008.40.5.486 (Pubitemid 352789088)
72. Vinuesa A. G., Sancho R., García-Limones C., Behrens A., Ten Dijke P., Calzado M. A., Muñoz E., Vanilloid receptor-1 regulates neurogenic inflammation in colon and protects mice from colon cancer. Cancer Research 2012 72 7 1705 1716 2-s2.0-84859402570 10.1158/0008-5472.CAN-11-3693
73. Lazzeri M., Vannucchi M. G., Spinelli M., Bizzoco E., Beneforti P., Turini D., Faussone-Pellegrini M.-S., Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. European Urology 2005 48 4 691 698 2-s2.0-24644523380 10.1016/j.eururo.2005.05.018 (Pubitemid 41278598)
74. Amantini C., Ballarini P., Caprodossi S., Nabissi M., Morelli M. B., Lucciarini R., Cardarelli M. A., Mammana G., Santoni G., Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis 2009 30 8 1320 1329 2-s2.0-69449089475 10.1093/carcin/bgp138
75. Caprodossi S., Amantini C., Nabissi M., Morelli M. B., Farfariello V., Santoni M., Gismondi A., Santoni G., Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis 2011 32 5 686 694 2-s2.0-79955749422 10.1093/carcin/bgr025
76. Surh Y.-J., More than spice: capsaicin in hot chili peppers makes tumor cells commit suicide. Journal of the National Cancer Institute 2002 94 17 1263 1265 2-s2.0-0037019748
77. Qiao S., Li W., Tsubouchi R., Haneda M., Murakami K., Yoshino M., Involvement of peroxynitrite in capsaicin-induced apoptosis of C6 glioma cells. Neuroscience Research 2005 51 2 175 183 2-s2.0-12844280531 10.1016/j.neures. 2004.10.006 (Pubitemid 40164953)
78. Gonzales C. B., Kirma N. B., De La Chapa J. J., Chen R., Henry M. A., Luo S., Hargreaves K. M., Vanilloids induce oral cancer apoptosis independent of TRPV1. Oral Oncology 2014 50 5 437 447
79. Itokawa H., Shi Q., Akiyama T., Morris-Natschke S. L., Lee K.-H., Recent advances in the investigation of curcuminoids. Chinese Medicine 2008 3, article 11 2-s2.0-55649088513 10.1186/1749-8546-3-11
80. Pan M.-H., Huang T.-M., Lin J.-K., Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition 1999 27 4 486 494 2-s2.0-0032926620 (Pubitemid 29177642)
81. Osawa T., Sugiyama Y., Inayoshi M., Kawakishi S., Antioxidative activity of tetrahydrocurcuminoids. Bioscience, Biotechnology, and Biochemistry 1995 59 9 1609 1612 2-s2.0-0029367274
82. Sugiyama Y., Kawakishi S., Osawa T., Involvement of the β -diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochemical Pharmacology 1996 52 4 519 525 2-s2.0-0029979805 10.1016/0006-2952(96)00302-4 (Pubitemid 26253384)
83. Lai C.-S., Wu J.-C., Yu S.-F., Badmaev V., Nagabhushanam K., Ho C.-T., Pan M.-H., Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Molecular Nutrition and Food Research 2011 55 12 1819 1828 2-s2.0-82955170666 10.1002/mnfr.201100290
84. Shehzad A., Wahid F., Lee Y. S., Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Archiv der Pharmazie 2010 343 9 489 499 2-s2.0-77956863976 10.1002/ardp. 200900319
85. Shehzad A., Rehman G., Lee Y. S., Curcumin in inflammatory diseases. Biofactors 2013 39 1 69 77
86. Cheng T.-C., Lu C.-C., Chung H.-H., Hsu C.-C., Kakizawa N., Yamada S., Cheng J.-T., Activation of muscarinic M-1 cholinoceptors by curcumin to increase contractility in urinary bladder isolated from Wistar rats. Neuroscience Letters 2010 473 2 107 109 2-s2.0-77949914130 10.1016/j.neulet.2010.02.029
87. Arafa H. M. M., Uroprotective effects of curcumin in cyclophosphamide- induced haemorrhagic cystitis paradigm. Basic and Clinical Pharmacology and Toxicology 2009 104 5 393 399 2-s2.0-64549130896 10.1111/j.1742-7843.2009.00379. x
88. Lu Q., Jiang F., Xu R., A pilot study on intravesical administration of curcumin for cystitis glandularis. Evidence-Based Complementary and Alternative Medicine 2013 2013 5 269745 10.1155/2013/269745
89. Olivera A., Moore T. W., Hu F., Brown A. P., Sun A., Liotta D. C., Snyder J. P., Yoon Y., Shim H., Marcus A. I., Miller A. H., Pace T. W. W., Inhibition of the NF- B signaling pathway by the curcumin analog, 3,5-Bis(2- pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. International Immunopharmacology 2012 12 2 368 377 2-s2.0-84856741618 10.1016/j.intimp.2011.12.009
90. Dorai T., Gehani N., Katz A., Therapeutic potential of curcumin in human prostate cancer-I. Curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer and Prostatic Diseases 2000 3 2 84 93 2-s2.0-0033843216 (Pubitemid 30665213)
91. Cimino S., Sortino G., Favilla V., Castelli T., Madonia M., Sansalone S., Russo G. I., Morgia G., Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxidative Medicine and Cellular Longevity 2012 2012 8 632959 10.1155/2012/632959
92. Sundram V., Chauhan S. C., Ebeling M., Jaggi M., Curcumin attenuates β -catenin signaling in prostate cancer cells through activation of protein kinase D1. PLoS ONE 2012 7 4 2-s2.0-84859868412 10.1371/journal.pone.0035368 e35368
93. Capodice J. L., Gorroochurn P., Cammack A. S., Goluboff E., McKiernan J. M., Benson M. C., Stone B. A., Katz A. E., Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial. Journal of the Society for Integrative Oncology 2009 7 2 43 51 2-s2.0-67649394453 10.2310/7200.2009.0012
94. Tian B., Wang Z., Zhao Y., Wang D., Li Y., Ma L., Li X., Li J., Xiao N., Tian J., Rodriguez R., Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Letters 2008 264 2 299 308 2-s2.0-42749090720 10.1016/j.canlet.2008.01.041
95. Chadalapaka G., Jutooru I., Chintharlapalli S., Papineni S., Smith R. III, Li X., Safe S., Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Research 2008 68 13 5345 5354 2-s2.0-48549085442 10.1158/0008-5472.CAN-07-6805
96. Watanabe F. T., Chade D. C., Reis S. T., Piantino C., dall'Oglio M. F., Srougi M., Leite K. R. M., Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model. Clinics 2011 66 12 2121 2124 2-s2.0-84455194859 10.1590/S1807-59322011001200019
97. Tharakan S. T., Inamoto T., Sung B., Aggarwal B. B., Kamat A. M., Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochemical Pharmacology 2010 79 2 218 228 2-s2.0-71749102389 10.1016/j.bcp.2009.08.007
98. Martelli L., Ragazzi E., Di Mario F., Martelli M., Castagliuolo I., Dal Maschio M., Palù G., Maschietto M., Scorzeto M., Vassanelli S., Brun P., A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterology and Motility 2007 19 8 668 674 2-s2.0-34447506660 10.1111/j.1365-2982.2007.00928.x (Pubitemid 47084123)
99. Sharma S., Kulkarni S. K., Agrewala J. N., Chopra K., Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. European Journal of Pharmacology 2006 536 3 256 261 2-s2.0-33646032364 10.1016/j.ejphar.2006.03.006
100. Mittal N., Joshi R., Hota D., Chakrabarti A., Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytotherapy Research 2009 23 4 507 512 2-s2.0-64549130895 10.1002/ptr.2662
101. Yeon K. Y., Kim S. A., Kim Y. H., Lee M. K., Ahn D. K., Kim H. J., Kim J. S., Jung S. J., Oh S. B., Curcumin produces an antihyperalgesic effect via antagonism of TRPV1. Journal of Dental Research 2010 89 2 170 174 2-s2.0-75649138334 10.1177/0022034509356169
102. Gallimore A. M., Godkin A., Epithelial barriers, microbiota, and colorectal cancer. The New England Journal of Medicine 2013 368 3 282 284